Skip to content

Advertisement

  • Study protocol
  • Open Access
  • Open Peer Review

Effect and neurophysiological mechanism of acupuncture in patients with chronic sciatica: protocol for a randomized, patient-assessor blind, sham-controlled clinical trial

Trials201920:56

https://doi.org/10.1186/s13063-018-3164-8

  • Received: 4 June 2018
  • Accepted: 22 December 2018
  • Published:
Open Peer Review reports

Abstract

Background

Sciatica is a relatively frequent illness that easily becomes a chronic and relapsing condition. Although numerous systematic reviews have analyzed various therapies for sciatica, the validity of their included studies is limited. Considering the limitations of conventional treatment options for sciatica, acupuncture is a possible option; however, evidence supporting its efficacy and mechanism in patients with sciatica is lacking. The aim of this proposed protocol is to investigate the effect and neurophysiological mechanism of acupuncture in patients with chronic sciatica.

Methods/design

This study is a randomized, patient-assessor blind, two-arm, parallel, non-penetrating, sham-controlled clinical trial. Eligible participants will include adults (aged 19–70 years old) with a clinical diagnosis of chronic sciatica (40 mm or more of a 100-mm visual analog scale (VAS) for bothersomeness) blinded to the treatment received. Patients will be randomly allocated into the acupuncture treatment group (manual acupuncture plus electroacupuncture (EA), n = 34) or the sham acupuncture control group (sham acupuncture plus placebo EA without electrical stimulation, n = 34). Groups will receive treatment twice a week for a total of eight sessions over 4 weeks. Functional magnetic resonance imaging will be implemented at baseline and endpoint to investigate the mechanism of acupuncture. The primary outcome measure is the VAS for bothersomeness and secondary outcomes include the VAS for pain intensity, Oswestry Disability Index, EuroQol 5-Dimension, Coping Strategy Questionnaire, Beck’s Depression Inventory, and State-Trait Anxiety Inventory. Adverse events will be assessed at every visit.

Discussion

The results of this trial (which will be available in 2020) should provide important clinical evidence for the effect of acupuncture and demonstrate how acupuncture can be helpful for the treatment of chronic sciatica.

Trial registration

ClinicalTrials.gov, ID: NCT03350789. Registered on 15 November 2017.

Keywords

  • Chronic sciatica
  • Acupuncture
  • Effect
  • Functional magnetic resonance imaging

Background

Sciatica is a type of neuropathic pain that includes aching and sharp pain components that radiate from the buttock downward along the course of the sciatic nerve [1, 2]. Of all patients suffering from sciatic pain, 85% of cases are associated with a disk disorder [3]. Symptoms of sciatic pain are frequent with the highest incidence of 40% and the pain easily progresses to a chronic and relapsing stage as disturbances anywhere along the course of the sciatic nerve can cause sciatica [4, 5]. Although numerous systematic reviews and guidelines have analyzed and compared various forms of treatment for sciatica [68], the outcomes and the cost of care have remained unchanged for more than a decade [9]. A systematic review concluded that evidence is conflicting regarding the long-term benefits of various strategies for chronic sciatica treatment despite the fact that these same treatments showed some support for short-term pain relief [10]. Recently, investigators have applied neuroimaging studies that explored changes in morphology and functional connectivity of the brain to gain a better understanding of pain and the pain-killing mechanism employed by the nervous system [1114]. Especially, neurophysiological studies for chronic pain are increasingly important, where the pain continues in spite of no stimulation or irritation and the condition is accompanied by changes in neuroplasticity and sensitization of the nervous system [1519].

Considering the limitations of conventional treatment options and the importance of understanding the neurophysiological mechanism in chronic pain, acupuncture could be a complementary and alternative treatment option for patients with chronic sciatica. Qin et al. [20] have shown the benefits of acupuncture in patients with sciatica through a systematic review of randomized controlled trials. While the results were affirmative, many of the included trials were of poor quality. Several studies on neuroimaging showed some changes in morphology and functional connectivity of the brain in patients with neuropathic pain such as from herniated intervertebral disk (HIVD) and sciatica [2126], indicating decreased functional connectivity of the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) in chronic sciatica [26]. One study demonstrated that acupuncture treatment for 4 weeks was effective in relieving clinical pain in patients with chronic low back pain (LBP), which correlated with a reverse in the abnormal default mode network (DMN) [27]. Another study showed that 10 acupuncture treatments recovered decreased functional connectivity of DLPFC and ACC in patients with chronic sciatica [26]. These results suggested the possible neurophysiological mechanism of acupuncture for chronic LBP and sciatica in the resting network state; however, these are only a part of the complex mechanism of pain and pain mitigation. Furthermore, few clinical trials have examined the effect of acupuncture on the parameters of emotion and coping strategy with neuroimaging in chronic sciatica patients, even though emotional state, perception, modulation, and chronification are extremely important part in chronic pain [28, 29].

Here, we propose a randomized, patient-assessor blind, sham-controlled study of patients with chronic sciatica with a predetermined sample size and appropriate follow-up following the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines [30] and Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) recommendations [31]. This protocol will help investigate the efficacy of acupuncture on chronic sciatica from the perspective of neuroimaging studies using functional magnetic resonance imaging (fMRI) with parameters of emotion and coping strategy to better understand the neurophysiological mechanism of acupuncture on chronic sciatica.

Methods/design

Objective

We hypothesize that acupuncture may have a better effect relative to good tolerance in patients with chronic sciatica than sham acupuncture. The aim of this study is to compare the efficacy and safety of acupuncture versus sham acupuncture on bothersomeness, pain, and functional dysfunction due to chronic sciatica. Additionally, neuroimaging studies using fMRI with parameters of emotion and coping strategy will be conducted to better understand the neurophysiological mechanism of acupuncture on chronic pain and related emotional state, perception, modulation, and chronification.

Study design

This clinical research protocol is designed to assess the effect and mechanism of acupuncture for chronic sciatica on pain and associated emotional disorder and will be processed with a randomized, two-arm, parallel, patient-assessor blinded, and non-penetrating sham-acupuncture controlled study. The trial will be performed in the Korean Medicine Hospital of Kyung Hee University at Gangdong in Korea. All participants will be enrolled through voluntary participation and written informed consent will be obtained in accordance with the Declaration of Helsinki and the Guidelines for Good Clinical Practice. Interventions for a given trial participant may be discontinued at any time during the trial based on participant request to discontinue or in cases of significant clinical worsening as judged by Doctors of Korean Medicine (DKMs). This protocol is registered with the U.S. National Institutes of Health Clinical Trials registry (NCT03350789). Eligible participants will be randomly allocated into one of two groups at a 1:1 allocation ratio, blinded to the group allocation, and receive treatment for 4 weeks. The experimental group will undergo real acupuncture treatment (verum manual acupuncture plus electroacupuncture (EA)) and the control group will undergo sham acupuncture treatment (acupuncture without skin penetration plus EA without electrical stimulation) twice a week. The effect on parameters related to bothersomeness, pain, and emotional disorder will be assessed at baseline and endpoint. The fMRI scanning will be conducted for 52 subjects (20 among the 34 experimental subjects, 20 among the 34 sham control subjects, and an additional 12 normal control subjects without any intervention; the normal control group of 12 subjects is for the analysis of fMRI data, not for the main analysis of the primary outcome, the VAS for bothersomeness as they do not have chronic sciatica and do not receive any interventions. They just serve as the normal control with fMRI scans performed twice) at baseline and endpoint. Outcome assessment and statistical analyses will be performed by professionals blinded to the assignment of participants to either the real or sham acupuncture groups. The study flow chart is presented in Fig. 1 and the trial timetable is depicted in Fig. 2.
Fig. 1
Fig. 1

The study flow chart

Fig. 2
Fig. 2

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure of enrollment, interventions, and assessments. EA electroacupuncture, VAS visual analog scale, ODI Oswestry Disability Index, EQ-5D EuroQol five-dimensional questionnaire, CSQ Coping Strategy Questionnaire, BDI Beck’s Depression Inventory, STAI State-Trait Anxiety Inventory

Participants

Inclusion criteria

A total of 68 patients (with an additional 12 patients as the normal control group for the fMRI data analysis) will be recruited through advertisements in local newspapers, monthly hospital magazines, on the hospital website, and on bulletin boards to achieve adequate enrollment and reach target sample size:
  1. 1.

    Participants from 19 to 70 years of age

     
  2. 2.

    Participants with clinical diagnosis of chronic sciatica (pain lasting 3 months or more)

     
  3. 3.

    Participants with a bothersomeness score on the VAS ≥ 40 mm

     
  4. 4.

    Participants who have voluntarily agreed to participate in the study and have signed written informed consent

     

Exclusion criteria

  1. 1.

    Participants previously having spinal surgery during the last 6 months

     
  2. 2.

    Participants previously or currently diagnosed with specific severe diseases resulting in sciatica (e.g., malignant tumor, spinal infection, inflammatory spondylitis)

     
  3. 3.

    Participants with progressive neurological deficit or severe neurological signs

     
  4. 4.

    Participants currently having other chronic diseases that could disturb the effect of treatments and the results of the study, including cardiovascular diseases, autoimmune diseases, renal diseases, diabetic neuropathy, dementia, epilepsy

     
  5. 5.

    Participants for whom acupuncture/EA may potentially be inadequate or unsafe (e.g., hemorrhagic diseases, anticoagulant medication, severe diabetes mellitus vulnerable to infections, serious cardiovascular diseases/pacemaker, metal materials in the interior of the body)

     
  6. 6.

    Participants who are currently pregnant or planning to become pregnant

     
  7. 7.

    Participants with a history of severe mental illness

     
  8. 8.

    Participants currently participating other clinical trials

     
  9. 9.

    Participants previously or currently receiving acupuncture or EA treatment for sciatica or taking medicines that might affect pain symptoms (e.g., corticosteroids, narcotics, non-steroidal anti-inflammatory drugs (NSAIDs)) or considered to be inadequate by the investigators during the last week (but they could be included only after going through 2 weeks of the wash out period)

     
  10. 10.

    Participants lacking capacity to give informed consent

     
  11. 11.

    Participants for whom MRI scanning may potentially be inadequate or unsafe (e.g., claustrophobia, metal materials in the interior of the body)

     
  12. 12.

    Other reasons for exclusion in this trial, including unwillingness to comply with the study protocol or inability to complete the study-related questionnaires by themselves or with assistance, as assessed by researchers

     

Randomization, allocation concealment, and blinding

Study participants who meet the eligibility criteria will be randomly assigned to two groups (the acupuncture treatment group or the sham acupuncture control group) in a 1:1 ratio at the second visit after signing written informed consent. Randomization will be conducted using a computer-generated random allocation sequence using SAS 9.4 (SAS Institute Inc., Cary, NC, USA) by a statistician with no clinical involvement in this trial and the random code (maintained in a sealed envelope) will be kept by a clinician who will not contact patients. Blocked randomization will be employed to ensure balance within the two groups.

Subject details will be recorded and a treatment arm and randomization number will be allocated to the subject. The randomization code will be released in the order of sequence after the participants are recruited for the trial and all baseline measures will be taken to ensure allocation concealment. The practitioners will be aware of the allocation arm while the subjects, outcome assessors, and statisticians performing the data analysis will be blinded to the treatment allocation [32]. The blinding index of the acupuncture and sham acupuncture treatments [33], previous experience and knowledge of acupuncture treatment [34], and needle sensation during acupuncture treatment [35] will be evaluated after the first acupuncture treatment, while the credibility and expectancy test will be assessed before the first treatment at baseline.

Education on study procedure standardization

We developed standard operating procedures (SOPs) for the entire trial and researchers will participate in clinical trial training according to their individual roles based on the SOPs. The process of the study, visit schedule notification, and financial compensation will be explained to participants to ensure their adherence to the protocol.

Intervention

Both real and sham acupuncture groups will receive a total of eight acupuncture sessions. At the time of the first acupuncture session, all participants will be given an “Exercise Manual for Patients with Sciatica” from the rehabilitation clinic of the Korean Medicine Hospital of Kyung Hee University at Gangdong. More detailed procedures according to the STRICTA are attached in Additional file 1.

Acupuncture treatment group

The acupuncture group will receive manual acupuncture plus EA treatment at the same time twice a week for 4 weeks, which is the common approach used by DKMs in South Korea today. The predefined acupuncture points will be carefully selected by a process of consensus with participating DKMs who all specialize in Rehabilitation Medicine of Korean Medicine on the basis of a literature review regarding acupuncture for LBP and sciatica. The seven essential acupuncture points selected are as follows: unilateral (the affected side) Huantiao (GB30) for manual acupuncture and Jiaji (EX-B2) points at L4 and L5, Shenshu (BL23), Dachangshu (BL25), Weizhong (BL40), and Yanglingquan (GB34) for EA. To make the acupuncture treatment reflect an ordinary clinical practice condition, additional individualized manual acupuncture points of 8 or less (a total of 15 or less acupuncture points with the seven essential points) will be chosen by the practitioners among the predefined group of optional acupuncture points categorized according to the three types of meridian patterns identification (Gallbladder meridian pattern, Bladder meridian pattern, and Mixed pattern) [36].

Manual acupuncture treatment will be administered using disposable sterile stainless-steel needles (40 mm × 0.25 mm; Dong-bang Acupuncture Inc., Seoul, Korea) to the acupuncture points mentioned above with the aid of the tube of sham acupuncture needle device. The needles will be inserted perpendicular to a depth of 5–20 mm with the patient lying face down after skin sterilization, followed by bidirectional rotation to induce Deqi sensation and left in place for 15 min.

At the same time, the six needles inserted to the predefined EA points will be connected to the ES-160 electrical stimulator. Electrical stimulation will consist of a biphasic waveform current, which utilizes alternating interrupted waves and continuous waves at 50 Hz in a triangular form and a compressional wave [37] for 15 min.

Sham acupuncture control group

The sham acupuncture group will receive non-penetrating sham acupuncture as control for manual acupuncture plus placebo acupuncture without electrical stimulation as the control for EA at the same time twice a week for 4 weeks.

Sham acupuncture treatment will be administered using non-penetrating disposable sterile stainless-steel sham needles (40 mm × 0.25 mm) as described by Park et al. (AcuPrime Co., Ltd., Exeter, UK) [38] to a total of 15 or less predefined non-traditional acupuncture points: 2 cm lateral to the each acupuncture point of the acupuncture group. Except for the use of a semi-blunted needle, the technique will be the same as performed in the acupuncture group.

At the same time, the six sham needles inserted to the predefined non-traditional EA points (2 cm lateral to each EA point of the real acupuncture group) will be connected to the ES-160 dummy device that is designed to have no electrical stimulation through insulation of electrodes and be left in place for 15 min.

Practitioner background

The acupuncture and sham treatments will be conducted by DKMs licensed by the Korean Ministry of Health and Welfare who specialize in Rehabilitation Medicine of Korean Medicine with at least 3 years of clinical experience. They have studied acupuncture for more than 10 years and graduated from a university of Korean Medicine. They will be required to take the educational course to strictly adhere to the study protocol and be familiar with administering study treatments. All practitioners will undergo intensive and customized training for a full understanding of the sham acupuncture procedure and will be trained to administer acupuncture using a sham needle device. The techniques for the entire treatment procedure will be standardized between practitioners.

fMRI scanning procedure

fMRI data will be acquired using an Ingenia 3.0 Tesla MRI scanner (Philips Medical System, Best, The Netherlands) equipped for echo planar imaging with an eight-channel head coil. For each of the fMRI series, the blood-oxygenation-level-dependent (BOLD) signal will be acquired using a whole-brain T2-weighted gradient echo pulse sequence (time to repetition [TR]/time to echo [TE] = 2000/35 ms, flip angle = 60°, 80 × 80 acquisition matrix, field of view (FOV) = 230 × 230 mm2, voxel size = 3 × 3 × 4 mm3, 34 inter-leaved axial slices) will be used. In addition to the fMRI data, we will collect structural data using a three-dimensional T1-weighted (3D-T1W) turbo field echo (TR/TE = 9886/4.59 ms, flip angle = 8°, FOV = 256 × 256 mm2, voxel size = 1 mm isotropic) to evaluate brain abnormalities and to analyze fMRI data. The diffusion tensor imaging (DTI) acquisition will be performed in the axial plane and will be obtained with the following imaging parameters: 32 directions, 52 contiguous slices each 2.2 mm thick without gaps between slices, TR 5260 ms, TE 64 ms, factor-b 0 and 800 s/mm2, 104 × 104 acquisition matrix, SENSE factor 2.5, FOV = 228 × 228 mm2. Participants will be asked to lie supine in the scanner while wearing earplugs to attenuate the gradient noise.

Subjects will participate in a pre-scan training session that is intended to familiarize them with the electrical stimulator used in TASK 1 and 2 and the computerized cuff-pressure algometry used in TASK 3 and to define their individual pain thresholds, followed by the imaging session, consisting of the REST scan run (6 min), TASK 1 (5 min), 3D-T1W (5 min), TASK 2 (5 min), DTI (6 min), and TASK 3 (6 min) in sequence. The entire imaging session procedure is summarized in Fig. 3.
  1. (1)

    In the training session, participants will be introduced to the Stimuplex® HNS 12 (B. Braun Melsungen AG, Melsungen, Germany) electrical stimulator-induced 3 to 6-s bothersome stimuli and rating procedures for the bothersomeness and emotion stimulation model scan run (TASK 1 and 2). They will be also trained to pain induced by computerized cuff-pressure using the Hokanson® E20 (AG101, Bellevue, WA, USA) rapid cuff inflator system and rating procedures for the low-back-extension (LBE) pain-model scan run (TASK 3). Participant individual bothersomeness or pain thresholds will be defined by asking them to verbally rate their bothersomeness or pain using a 0–10 (0, no bothersomeness or pain; 10, intolerable bothersomeness or pain) numerical rating scale (NRS). The electrical current intensity (mA) of the electrical stimulator and the cuff pressure (mmHg) of the cuff inflator system will be set to target a bothersomeness or pain intensity of about 4 on the NRS

     
  2. (2)

    In the imaging session, fMRI and structural data will be acquired for the steady-state resting scan run (REST), event-related block design bothersomeness and emotion stimuli model scan run (TASK 1), structural image acquisition using three-dimensional T1-weighted turbo field echo (3D-T1W), event-related block design bothersomeness and emotion stimuli model scan run (TASK 2), diffusion tensor imaging (DTI), and the steady-state LBE pain-model scan run (TASK 3)

    Both TASK 1 and 2 will consist of a block design with 20 6-s bothersomeness and emotion stimulation blocks, which will be followed by 9-s inter-stimulus interval (ISI) blocks in order to prevent anticipation during the measurements. The 20 stimuli of bothersomeness and emotion will be comprised of five types of stimuli (bothersomeness only, emotion (neutral) only, emotion (negative) only, bothersomeness and emotion (neutral), bothersomeness and emotion (negative)) and arranged in pseudo-random order. Bothersome stimuli will be delivered with the Stimuplex® HNS 12 electrical stimulator onto the low back of the ipsilateral side of the sciatica using the StiMus® surface electrode (HUREV Co., Ltd., Gangwon-do, Korea). Emotions will be elicited by utilizing stimuli from the standardized International Affective Picture System (IAPS) [39, 40], which has been frequently used in neuroimaging studies. IAPS pictures with human content will be used in the present study. Table 1 presents the reported valence and arousal of the 16 negative and 16 neutral IAPS pictures used. We selected pictures that have low differences in valence and arousal between sexes when there is often quite a difference according to gender in the IAPS pictures. The images will be projected through a goggle onto a screen in the MRI scanner. During the ISI and bothersome stimuli alone, a black screen will be displayed. The IAPS pictures will be shown for 6 s and in the combination of picture and bothersome stimuli, the bothersome stimulus will be delivered 3 s after the onset of the picture, based on studies on startle responses and physiological response times for emotional stimuli [41, 42].

    In TASK 3, the LBE model of endogenous LBP will be applied for the steady-state pain scan run. By inflating a cuff bladder made of rubber under the most painful area of the lower back, the extension angle of the lower back increases to induce pain. The cuff inflator (located in the control room) will be connected to the cuff bladder through a rubber tube so that the applied air pressure to the cuff bladder can be controlled according to patient response by manual operation outside the scanner.

     
Fig. 3
Fig. 3

Functional magnetic resonance imaging experiment paradigm (REST steady-state resting run; TASK 1/2 block design bothersomeness and emotion stimulus run; 3D-T1W structural image acquisition using 3-dimensional T1-weighted turbo field echo; DTI diffusion tensor imaging; TASK 3 low-back-extension pain-model steady-state run)

Table 1

The means and standard deviations (SDs) for valence and arousal of the groups to the International Affective Picture System (IAPS) items used in the study

 

Negative emotion

Neutral emotion

Male

Female

Male

Female

Valence, mean (SD)

2.66 (0.40)

2.28 (0.54)

5.11 (0.27)

5.08 (0.34)

Arousal, mean (SD)

4.65 (0.60)

5.12 (0.71)

3.43 (0.56)

3.47 (0.61)

IAPS sequence number

2141, 2205, 2455, 2590, 2700, 2750, 2799, 2800, 3220, 3230, 3350, 6311, 6570, 9220, 9265, 9415

2038, 2102, 2191, 2215, 2220, 2235, 2357, 2383, 2393, 2396, 2397, 2410, 2445, 2487, 2495, 2499

fMRI and DTI data processing

The acquired fMRI and structural data will be processed with conventional analysis packages including FMRIB’s Software Library (FSL; http://fsl.fmrib.ox.ac.uk/fsl) AFNI (Analysis of Functional NeuroImages; https://afni.nimh.nih.gov/afni), and FreeSurfer (https://surfer.nmr.mgh.harvard.edu/) in data processing steps including physiological noise correction (3dretroicor, AFNI), head motion correction (mcflirt, FSL), skull stripping for fMRI data (BET, FSL) and structural data (mri_watershed, FreeSurfer), brain to brain registration (FLIRT and FNIRT, FSL) and statistical analysis.

Outcome

Primary outcome measurement

The primary outcome measure is the bothersomeness of chronic sciatica as assessed by VAS [43]. To understand the impact of chronic sciatica on the patients, we decided to use the VAS for bothersomeness as the primary outcome measurement other than the VAS for pain intensity. Bothersomeness will be quantified using the VAS score as determined on a 100-mm horizontal line (0, no bothersomeness; 100, intolerable bothersomeness). Participants will be asked to mark the degree of bothersomeness due to sciatica experienced during the previous week at baseline (visit 2), before each treatment session (visits 2–9), and at each post-treatment follow-up visit (visits 10–11); the primary endpoint will be VAS for bothersomeness score at visit 10, i.e., 1 week after completion of the eight sessions of acupuncture treatment. The outcome measures will be assessed before treatment at each visit.

Secondary outcome measurements

VAS for pain intensity of chronic sciatica will be measured in the same fashion as VAS for bothersomeness (0, no pain; 100, intolerable pain) at baseline (visit 2), before each treatment session (visits 2–9), and at each post-treatment follow-up visit (visits 10–11). Since one of the goals of this study is to demonstrate the mechanism of acupuncture on chronic pain, we decided to use the VAS for pain intensity, for it is a fast and straightforward measure for assessing subjective intensity of pain [44].

The Oswestry Disability Index (ODI) [45] will be used to assess disability or dysfunction related to sciatica. The ODI consists of 10 questions on daily activities including: (1) experiencing general pain, (2) practicing self-care (e.g., washing, dressing), (3) lifting objects, (4) sitting, (5) standing, (6) walking, (7) sleeping, (8) travelling, (9) engaging in sexual activity if applicable, and (10) participating in social activities. Each item is rated on a 6-point scale (0–5), with lower scores indicating less pain-related disability. Participants will be asked to complete the validated Korean version of the ODI at baseline (visit 2) and at each post-treatment follow-up (visits 10–11).

The EuroQol 5-dimension (EQ-5D) [46] scale will be employed for health-related quality of life in patients with chronic sciatica. The EQ-5D consists of five dimensions including: (1) usual activities, (2) mobility, (3) pain/discomfort, (4) anxiety/depression, and (5) self-care. Each dimension is rated on a 1- to 3-point scale, with lower scores representing better health status. Participants will be asked to complete the validated Korean version of the EQ-5D at baseline (visit 2) and at each post-treatment follow-up (visits 10–11).

The Coping Strategies Questionnaire (CSQ) [47] will be used to evaluate the coping strategy for pain or acupuncture treatment. The CSQ is made up of 48 items across eight areas classified as either adaptive coping or maladaptive coping: (1) catastrophizing, (2) distractor behaviors, (3) self-instructions, (4) ignoring the pain, (5) reinterpreting the pain, (6) hoping, (7) faith and praying, and (8) cognitive distraction. Each item is rated on a 7-point Likert scale. The CSQ will be administered at baseline (visit 2) and at each post-treatment follow-up (visits 10–11).

The Korean version of Beck’s Depression Inventory (BDI) [48] will be used to measure depressive symptoms at baseline (visit 2) and at each post-treatment follow-up (visits 10–11). The BDI is a 21-item self-administered questionnaire with each item having a 0–3 point response format and a maximum theoretical score of 63. The psychometric quality of this test is very good [49].

The State-Trait Anxiety Inventory (STAI) [50] will be used to evaluate anxiety as a psychological factor at baseline (visit 2) and at each post-treatment follow-up (visits 10–11). The STAI consists of 40 items including: 20 items on the state of anxiety, which is triggered by a specific event and 20 items on the trait of anxiety, which is derived from personal characteristics. Each item is rated on a 4-point Likert scale, with lower scores indicating a lower degree of anxiety.

Adverse events

Any expected or unexpected adverse events (AEs) will be recorded and described as frequency and percentage by the participants and practitioners at every visit until completion. Participants will be given notice of any cautions and possible AEs before the fMRI scanning and the acupuncture treatment. The AEs known as being related to acupuncture treatment include local bleeding or pain at the acupuncture points, local redness or bruising, and itching and dizziness during treatment [51]. If any serious AEs occur, detailed events including the date of occurrence, measures taken related to the treatment, causal relationship with the treatment, and treatment of the AEs will be announced immediately to the principal investigator and the Institutional Review Board (IRB) and direct actions will be supplied to those involved.

Sample size

Referring to a previous study [52], an appropriately powered full-scale sample size was estimated using the mean difference of VAS for bothersomeness due to sciatica between groups in the primary endpoint. The researchers expect the mean difference will be 12.4 mm with a standard deviation (SD) of 16.2 mm between the two groups, which is not moderately clinically meaningful but represents a minimally important difference [53].

Considering the mean comparison method of the two-sample t test model with a two-tailed test, 80% test power, and a 5% significance level, the total number of individuals required per group is 27. For equal allocation of the two groups, the total sample size required when considering a dropout rate of 20% is 68 subjects with 34 subjects in each group.

Considering the nature of fMRI studies that use approximately 90,000 voxels to estimate the BOLD signal indirectly and for which conventional power calculations are meaningless, we determined 20 subjects in each group for fMRI scanning according to the trend of related neuroimaging studies [5458]. Most studies decided that 20 participants is an adequate sample size regarding the high cost of fMRI examinations.

Statistical analysis

All analyses will be performed using Statistical Package for Social Science (SPSS) for Windows (version 18.0; IBM Corp., Armonk, NY, USA) by a statistician blinded to the allocation of groups and the significance level will be set at 0.05. Statistical analyses will be conducted using the principle of the intention-to-treat (ITT) and the per-protocol (PP) analysis. We will apply the multiple imputation analysis for ITT analysis.

A paired t test (parametric) or Wilcoxon signed-rank test (non-parametric) will be used to compare continuous variables within groups. The two-sample t test (parametric) or the Mann-Whitney U test (non-parametric) for quantitative data and chi-square test or Fisher’s exact test for qualitative data will be performed to test differences between groups. Analysis of covariance (ANCOVA) will be used for adjustment of baseline characteristics if there is possibility of covariance. Repeated measure analysis of variance (ANOVA) will be performed for the different time point assessments between groups and interaction between groups and observed time. A mixed-model approach will also be used if necessary.

Statistical analysis for fMRI data will be completed via a general linear model (GLM) analysis (FEAT, FSL) and probabilistic independent component analysis (pICA using MELODIC, FSL). In performing GLM analysis, estimated responses from estimating regressors including stimulus function (block design) and nuisance regressors will be compared using a t test with the time series data in each brain voxel so that we can identify the specific brain responses to the visual and bothersome stimulus in TASK 1 and 2. pICA will be applied for fMRI data from REST and TASK 3 runs for brain functional connectivity analysis. In pICA processing, it assumes that the intrinsic sources in the data are non-Gaussian and the data can be inferred by Bayesian estimation of Gaussian noise. Then, the data can be projected in lower dimensional subspace and we can estimate the independent intrinsic component maps.

Data collection, management, and monitoring

The data will be collected through paper-based documents written by the clinical research coordinator and outcome assessors. All original data sources will be stored in limited-access areas for 3 years. A clinical research associate independent from the funder and competing interests will monitor the clinical trial during the study period. The clinical research associate will monitor the written informed consent documents, recruitment status, protocol compliance, overall trial progress, data quality, timelines of data collection, treatment administration, and other relevant trial aspects and processes. The Ministry of Food and Drug Safety (MFDS) in Korea will carry out audits at regular intervals.

Discussion

A systematic review of acupuncture for treating sciatica found that the use of acupuncture may be more effective than drugs and may enhance the effect of drugs for patients with sciatica, but because of the insufficient number of relevant and rigorous studies, the evidence is limited [20]. Among the included 11 studies, six used EA, two used manual acupuncture, and three used warming acupuncture as intervention. We adopted a complex intervention of manual acupuncture plus EA treatment because it is the most common approach used by DKMs in South Korea today.

Recently, neurophysiological studies for chronic pain are increasing [1519] because emotional state, perception, modulation, and chronification all play an extremely important role in chronic pain [28, 29]. Kaneko et al. [59] demonstrated that the presence of psychiatric problems was associated with attenuated activity of the nucleus accumbens (NAc) in chronic LBP and dysfunction of the NAc might potentially be involved in the affective/motivational factors in the chronification of LBP. Thus, we designed a study protocol to examine the effect of acupuncture on parameters of emotion and coping strategy with neuroimaging as well as bothersomeness and pain intensity in patients with chronic sciatica.

In the fMRI scanning session, both TASK 1 and 2 were designed to investigate the interaction between negative and neutral emotional states and experimental bothersomeness in the essential pain-processing network [60]. As we decided to use the VAS for bothersomeness as the primary outcome measurement other than the VAS for pain intensity to understand the impact of chronic pain on patients in this study, we adopted this bothersomeness and emotion stimuli model scan run using the StiMus® MRI-compatible surface electrode to induce experimental bothersome stimuli other than pain stimuli. In TASK 3, we selected the LBE pain model because it is intuitive and has a simple methodology, induces a similar pain sensation to clinical pain in patients, and is a MRI-compatible pain model for neuroimaging study [61, 62]. The fMRI data analysis will be conducted to compare not only the acupuncture group with sham control group but will also compare responders with non-responders.

We chose non-penetrating sham acupuncture plus placebo acupuncture without electrical stimulation at non-traditional acupuncture points for the control group. Park et al. validated the complete subject blinding of sham acupuncture as the control group [38], and we will evaluate the blinding index [33] of the acupuncture and sham acupuncture treatments after the first acupuncture treatment and at endpoint. For valid blinding of placebo EA, the ES-160 dummy device was designed to have no electrical stimulation by insulating electrodes, similar to a previous study [63]. The intensity of electrical stimulation from both real and sham devices will be maintained under a certain level so that subjects in either group cannot perceive the electric current. Patients will be informed about the two types of acupuncture in the study as follows: “In this study, different types of acupuncture will be compared. The electric current will flow but with intensity under a fixed level which you cannot detect.”

This randomized, patient-assessor blind, sham-controlled clinical trial should provide important evidence for the efficacy of acupuncture for chronic sciatica and will help improve our understanding of the neurophysiological mechanism of acupuncture on the interaction between emotional state and chronic pain. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Checklist for this protocol is attached in Additional file 2.

Study limitations

Due to the nature of clinical research on acupuncture, practitioner blinding is impossible. Instead, we adopted the design of patient-assessor blinding, the best way of masking in acupuncture studies. Also, there is no limit on gender for enrollment, though the IAPS pictures used in TASK 1 and 2 of fMRI scanning session often have quite a different valence and arousal according to the gender [39, 40]. Thus, we selected pictures that have low differences in valence and arousal between sexes and subgroup analysis will be conducted.

Trial status

Recruitment began in March 2018.

Abbreviations

3D-T1W: 

Three-dimensional T1-weighted

ACC: 

Anterior cingulate cortex

AE: 

Adverse events

AFNI: 

Analysis of Functional NeuroImages

ANCOVA: 

Analysis of covariance

ANOVA: 

Analysis of variance

BDI: 

Beck’s Depression Inventory

BOLD: 

Blood-oxygenation-level-dependent

CSQ: 

Coping Strategy Questionnaire

DKM: 

Doctor of Korean Medicine

DLPFC: 

Dorsolateral prefrontal cortex

DMN: 

Default mode network

DTI: 

Diffusion tensor imaging

EA: 

Electroacupuncture

EQ-5D: 

EuroQol five-dimensional questionnaire

fMRI: 

Functional magnetic resonance imaging

FOV: 

Field of view

FSL: 

FMRIB’s Software Library

GLM: 

General linear model

HIVD: 

Herniated intervertebral disk

IAPS: 

International Affective Picture System

IRB: 

Institutional Review Board

ISI: 

Inter-stimulus interval

ITT: 

Intention-to-treat

LBE: 

Low back extension

LBP: 

Low back pain

NAc: 

Nucleus accumbens

NRS: 

Numerical rating scale

ODI: 

Oswestry Disability Index

PP: 

Per-protocol

SD: 

Standard deviation

SOP: 

Standard operating procedure

SPIRIT: 

Standard Protocol Items: Recommendations for Interventional Trials

SPSS: 

Statistical Package for Social Science

STAI: 

State-Trait Anxiety Inventory

STRICTA: 

Standards for Reporting Interventions in Clinical Trials of Acupuncture

TE: 

Time to echo

TR: 

Time to repetition

VAS: 

Visual analog scale

Declarations

Acknowledgements

The authors would like to appreciate the contributions of all the participants.

Funding

The research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF-2017R1A2B4011707).

Availability of data and materials

The raw data will be made available by the authors, without undue reservation, to any qualified researcher.

Authors’ contributions

KWK was involved in drafting the manuscript. KP and SE participated in the design of the statistical analyses and the outcome measurements. HJP, GHJ, DJJ, and JHC made substantial contributions to conception of the study and designed overall scientific management. EMS, WCS, YJY, and SJK provided critiques and revised the article for important intellectual content. MYS participated in the critical revision of the manuscript and had final responsibility for the decision to submit for publication. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The research protocol was reviewed and approved by the IRB of the Korean Medicine Hospital of Kyung Hee University at Gangdong [KHNMCOH 2017-08-004]. Any important protocol modifications will be made known to relevant parties and/or individuals (e.g., investigators, IRB, trial participants, and funder). The study results will be disseminated in a peer-reviewed medical journal and presented at international conferences. Written informed consent will be obtained from all participants prior to enrollment into the study by the investigator.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea
(2)
East-West Medical Research Institute, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea
(3)
Department of Biomedical Engineering, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 17104, Republic of Korea
(4)
Studies of Translational Acupuncture Research, Acupuncture and Meridian Science Research Center, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea
(5)
Department of Radiology, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, 892 Dongnam-ro, Gangdong-gu, Seoul, 05278, Republic of Korea
(6)
Department of Neurosurgery, Spine Center, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, 892 Dongnam-ro, Gangdong-gu, Seoul, 05278, Republic of Korea

References

  1. Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015;372:1240–8.View ArticleGoogle Scholar
  2. Frymoyer JW. Back pain and sciatica. N Engl J Med. 1988;318:291–300.View ArticleGoogle Scholar
  3. Porchet F, Wietlisbach V, Burnand B, Daeppen K, Villemure JG, Vader JP. Relationship between severity of lumbar disc disease and disability scores in sciatica patients. Neurosurgery. 2002;50:1253–9 discussion 1259-60.PubMedGoogle Scholar
  4. Lindblom K, Rexed B. Spinal nerve injury in dorso-lateral protrusions of lumbar disks. J Neurosurg. 1948;5:413–32.View ArticleGoogle Scholar
  5. Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine (Phila Pa 1976). 2008;33:2464–72.View ArticleGoogle Scholar
  6. Lewis RA, Williams NH, Sutton AJ, Burton K, Din NU, Matar HE, et al. Comparative clinical effectiveness of management strategies for sciatica: systematic review and network meta-analyses. Spine J. 2015;15:1461–77.View ArticleGoogle Scholar
  7. Luijsterburg PA, Verhagen AP, Ostelo RW, van Os TA, Peul WC, Koes BW. Effectiveness of conservative treatments for the lumbosacral radicular syndrome: a systematic review. Eur Spine J. 2007;16:881–99.View ArticleGoogle Scholar
  8. Valat JP, Genevay S, Marty M, Rozenberg S, Koes B. Sciatica. Best Pract Res Clin Rheumatol. 2010;24:241–52.View ArticleGoogle Scholar
  9. Mafi JN, McCarthy EP, Davis RB, Landon BE. Worsening trends in the management and treatment of back pain. JAMA Intern Med. 2013;173:1573–81.View ArticleGoogle Scholar
  10. Jacobs WC, van Tulder M, Arts M, Rubinstein SM, van Middelkoop M, Ostelo R, et al. Surgery versus conservative management of sciatica due to a lumbar herniated disc: a systematic review. Eur Spine J. 2011;20:513–22.View ArticleGoogle Scholar
  11. DeSouza DD, Davis KD, Hodaie M. Reversal of insular and microstructural nerve abnormalities following effective surgical treatment for trigeminal neuralgia. Pain. 2015;156:1112–23.PubMedGoogle Scholar
  12. Lutz A, McFarlin DR, Perlman DM, Salomons TV, Davidson RJ. Altered anterior insula activation during anticipation and experience of painful stimuli in expert meditators. NeuroImage. 2013;64:538–46.View ArticleGoogle Scholar
  13. Vasic V, Schmidt MH. Resilience and vulnerability to pain and inflammation in the hippocampus. Int J Mol Sci. 2017;18. https://doi.org/10.3390/ijms18040739.
  14. Gard T, Holzel BK, Sack AT, Hempel H, Lazar SW, Vaitl D, et al. Pain attenuation through mindfulness is associated with decreased cognitive control and increased sensory processing in the brain. Cereb Cortex. 2012;22:2692–702.View ArticleGoogle Scholar
  15. Apkarian AV, Hashmi JA, Baliki MN. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain. 2011;152:S49–64.View ArticleGoogle Scholar
  16. Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14:502–11.View ArticleGoogle Scholar
  17. Baliki MN, Geha PY, Fields HL, Apkarian AV. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron. 2010;66:149–60.View ArticleGoogle Scholar
  18. Jiang Y, Oathes D, Hush J, Darnall B, Charvat M, Mackey S, et al. Perturbed connectivity of the amygdala and its subregions with the central executive and default mode networks in chronic pain. Pain. 2016;157:1970–8.View ArticleGoogle Scholar
  19. Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci. 2012;32:5747–56.View ArticleGoogle Scholar
  20. Qin Z, Liu X, Wu J, Zhai Y, Liu Z. Effectiveness of acupuncture for treating sciatica: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2015;2015:425108.PubMedPubMed CentralGoogle Scholar
  21. Sharma HA, Gupta R, Olivero W. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Res. 2011;4:401–5.View ArticleGoogle Scholar
  22. Luchtmann M, Steinecke Y, Baecke S, Lutzkendorf R, Bernarding J, Kohl J, et al. Structural brain alterations in patients with lumbar disc herniation: a preliminary study. PLoS One. 2014;9:e90816.View ArticleGoogle Scholar
  23. Seminowicz DA, Wideman TH, Naso L, Hatami-Khoroushahi Z, Fallatah S, Ware MA, et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J Neurosci. 2011;31:7540–50.View ArticleGoogle Scholar
  24. Baliki MN, Petre B, Torbey S, Herrmann KM, Huang L, Schnitzer TJ, et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci. 2012;15:1117–9.View ArticleGoogle Scholar
  25. Mao CP, Zhang QL, Bao FX, Liao X, Yang XL, Zhang M. Decreased activation of cingulo-frontal-parietal cognitive/attention network during an attention-demanding task in patients with chronic low back pain. Neuroradiology. 2014;56:903–12.View ArticleGoogle Scholar
  26. Li J, Dong JC, Yue JJ. Effects of acupuncture on default mode network images of chronic sciatica patients in the resting network state. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32:1624–7.PubMedGoogle Scholar
  27. Li J, Zhang JH, Yi T, Tang WJ, Wang SW, Dong JC. Acupuncture treatment of chronic low back pain reverses an abnormal brain default mode network in correlation with clinical pain relief. Acupunct Med. 2014;32:102–8.View ArticleGoogle Scholar
  28. Lu C, Yang T, Zhao H, Zhang M, Meng F, Fu H, et al. Insular cortex is critical for the perception, modulation, and chronification of pain. Neurosci Bull. 2016;32:191–201.View ArticleGoogle Scholar
  29. Hashmi JA, Baliki MN, Huang L, Baria AT, Torbey S, Hermann KM, et al. Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain. 2013;136:2751–68.View ArticleGoogle Scholar
  30. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28–55.View ArticleGoogle Scholar
  31. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement. J Evid Based Med. 2010;3:140–55.View ArticleGoogle Scholar
  32. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149–53.View ArticleGoogle Scholar
  33. Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials. 2004;25:143–56.View ArticleGoogle Scholar
  34. Lee H, Bang H, Kim Y, Park J, Lee S, Lee H, et al. Non-penetrating sham needle, is it an adequate sham control in acupuncture research? Complement Ther Med. 2011;19 Suppl 1:S41–8.View ArticleGoogle Scholar
  35. Park H, Park J, Lee H, Lee H. Does Deqi (needle sensation) exist? Am J Chin Med. 2002;30:45–50.View ArticleGoogle Scholar
  36. Cho YJ, Song YK, Cha YY, Shin BC, Shin IH, Park HJ, et al. Acupuncture for chronic low back pain: a multicenter, randomized, patient-assessor blind, sham-controlled clinical trial. Spine (Phila Pa 1976). 2013;38:549–57.View ArticleGoogle Scholar
  37. Jung YP, Jung HK, Chiang SY, Wi J, Yoon YC, Chae WS. The clinical study of electroacupuncture treatment at Hua-Uo-Jia-Ji-Xue on spondylolisthesis. J Korean Acupunct Moxibustion Soc. 2008;25:221–32.Google Scholar
  38. Park J, White A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002;20:168–74.View ArticleGoogle Scholar
  39. Lang PJ, Bradley MM, Cuthbert BN. International Affective Picture System (IAPS): technical manual and affective ratings. Gainesville: University of Florida, Center for Psychophysiology; 1997.Google Scholar
  40. Lang PJ, Bradley MM, Cuthbert BN. International Affective Picture System (IAPS): affective ratings of pictures and instruction manual. Florida: NIMH, Center for the Study of Emotion & Attention; 2005.Google Scholar
  41. Amrhein C, Muhlberger A, Pauli P, Wiedemann G. Modulation of event-related brain potentials during affective picture processing: a complement to startle reflex and skin conductance response? Int J Psychophysiol. 2004;54:231–40.View ArticleGoogle Scholar
  42. Bradley MM, Lang PJ. The International Affective Picture System (IAPS) in the study of emotion and attention. In: Coan JA, Allen JJB, editors. Handbook of emotion elicitation and assessment. New York: Cambridge University Press; 2007. p. 29–46.Google Scholar
  43. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16:87–101.View ArticleGoogle Scholar
  44. Revill SI, Robinson JO, Rosen M, Hogg MI. The reliability of a linear analogue for evaluating pain. Anaesthesia. 1976;31:1191–8.View ArticleGoogle Scholar
  45. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25:2940–52 discussion 2952.View ArticleGoogle Scholar
  46. Kang EJ, Shin SH, Park HJ, Jo MW, Kim NY. A validation of health status using EQ-5D. Korean J Health Econ Policy. 2006;12:19–43.Google Scholar
  47. Rodriguez Franco L, Cano Garcia FJ, Blanco Picabia A. Assessment of chronic pain coping strategies. Actas Esp Psiquiatr. 2004;32:82–91.PubMedGoogle Scholar
  48. Lee YH, Song JY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D Scales. Korean J Clin Psychol. 1991;10:98–113.Google Scholar
  49. Jo SA, Park MH, Jo I, Ryu SH, Han C. Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry. 2007;22:218–23.View ArticleGoogle Scholar
  50. Spielberger CD, Goursuch RL, Lushene RE. Manual for the State Trait Anxiety Inventory. Mountain View: Consulting Psychologist Press; 1983.Google Scholar
  51. Xu S, Wang L, Cooper E, Zhang M, Manheimer E, Berman B, et al. Adverse events of acupuncture: a systematic review of case reports. Evid Based Complement Alternat Med. 2013;2013:581203.PubMedPubMed CentralGoogle Scholar
  52. Zhang X, Wang Y, Wang Z, Wang C, Ding W, Liu Z. A randomized clinical trial comparing the effectiveness of electroacupuncture versus medium-frequency electrotherapy for discogenic sciatica. Evid Based Complement Alternat Med. 2017;2017:9502718.PubMedPubMed CentralGoogle Scholar
  53. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105–21.View ArticleGoogle Scholar
  54. Napadow V, LaCount L, Park K, As-Sanie S, Clauw DJ, Harris RE. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum. 2010;62:2545–55.View ArticleGoogle Scholar
  55. Harris RE, Zubieta JK, Scott DJ, Napadow V, Gracely RH, Clauw DJ. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). NeuroImage. 2009;47:1077–85.View ArticleGoogle Scholar
  56. Napadow V, Dhond RP, Kim J, LaCount L, Vangel M, Harris RE, et al. Brain encoding of acupuncture sensation—coupling on-line rating with fMRI. NeuroImage. 2009;47:1055–65.View ArticleGoogle Scholar
  57. Knight DC, Waters NS, King MK, Bandettini PA. Learning-related diminution of unconditioned SCR and fMRI signal responses. NeuroImage. 2010;49:843–8.View ArticleGoogle Scholar
  58. Grabenhorst F, Rolls ET. Different representations of relative and absolute subjective value in the human brain. NeuroImage. 2009;48:258–68.View ArticleGoogle Scholar
  59. Kaneko H, Zhang S, Sekiguchi M, Nikaido T, Makita K, Kurata J, et al. Dysfunction of nucleus accumbens is associated with psychiatric problems in patients with chronic low back pain: a functional magnetic resonance imaging study. Spine (Phila Pa 1976). 2017;42:844–53.View ArticleGoogle Scholar
  60. Orenius TI, Raij TT, Nuortimo A, Naatanen P, Lipsanen J, Karlsson H. The interaction of emotion and pain in the insula and secondary somatosensory cortex. Neuroscience. 2017;349:185–94.View ArticleGoogle Scholar
  61. Jespersen A, Dreyer L, Kendall S, Graven-Nielsen T, Arendt-Nielsen L, Bliddal H, et al. Computerized cuff pressure algometry: a new method to assess deep-tissue hypersensitivity in fibromyalgia. Pain. 2007;131:57–62.View ArticleGoogle Scholar
  62. Polianskis R, Graven-Nielsen T, Arendt-Nielsen L. Modality-specific facilitation and adaptation to painful tonic stimulation in humans. Eur J Pain. 2002;6:475–84.View ArticleGoogle Scholar
  63. Kim KW, Yoo HH, Cho JH, Yang YC, Kim JI, Kim SY, et al. Effects of acupuncture on serum metabolic parameters in premenopausal obese women: study protocol for a randomized controlled trial. Trials. 2015;16:327. https://doi.org/10.1186/s13063-015-0867-y.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2019

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement